We are live on ! Find out more
MG

Meditor Group Portfolio holdings

AUM $48.1M
1-Year Est. Return 38.67%
This Fund
S&P 500
This Quarter Est. Return
+6.61%
1 Year Est. Return
+38.67%
3 Year Est. Return
+41.15%
5 Year Est. Return
+72.2%
10 Year Est. Return
+1,065.64%
AUM
$709M
AUM Growth
-$29.3M
Cap. Flow
-$65.5M
Cap. Flow %
-9.23%
Top 10 Hldgs %
65.49%
Holding
47
New
7
Increased
7
Reduced
10
Closed
11

Top Buys

Rank Stock Value
1
JCP
J.C. Penney Company, Inc.
JCP
+$64.2M
2
BKS
Barnes & Noble
BKS
+$31.4M
3
DDS icon
Dillards
DDS
+$19.8M
4
SPY icon
State Street SPDR S&P 500 ETF Trust
SPY
+$18.1M
5
LIFE
LIFE TECHNOLOGIES CORP COM STK (DE)
LIFE
+$15.7M

Top Sells

Rank Stock Value
1
ONXX
ONYX PHARMACEUTICALS INC
ONXX
+$66.7M
2
GOOG icon
Alphabet (Google) Class C
GOOG
+$56.7M
3
BB icon
BlackBerry
BB
+$23.1M
4
SFD
SMITHFIELD FOODS,INC
SFD
+$21.3M
5
HPQ icon
HP
HPQ
+$12.6M

Sector Composition

Rank Sector Weight
1 Healthcare 46.72%
2 Consumer Discretionary 13.7%
3 Technology 5.86%
4 Financials 5.07%
5 Communication Services 4.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRK icon
1
Merck
MRK
$324B
$83.2M 11.73%
1,830,437
-125,760
-6% -$5.74M
EXEL icon
2
Exelixis
EXEL
$13.9B
$69.8M 9.85%
12,000,000
– –
ONXX
3
DELISTED
ONYX PHARMACEUTICALS INC
ONXX
$54.2M 7.65%
435,000
-527,103
-55% -$66.7M
ALKS icon
4
Alkermes
ALKS
$8.82B
$52.8M 7.44%
1,570,000
-130,000
-8% -$4.23M
JCP
5
DELISTED
J.C. Penney Company, Inc.
JCP
$39.6M 5.59%
+4,500,000
New +$64.2M
VVUS
6
DELISTED
Vivus Inc
VVUS
$39.1M 5.52%
420,730
– –
BKS
7
DELISTED
Barnes & Noble
BKS
$36.9M 5.2%
4,349,100
+3,013,850
+226% +$31.4M
NYX
8
DELISTED
NYSE EURONEXT INC
NYX
$32.6M 4.59%
776,070
– –
LIFE
9
DELISTED
LIFE TECHNOLOGIES CORP COM STK (DE)
LIFE
$32M 4.51%
427,000
+210,000
+97% +$15.7M
HPQ icon
10
HP
HPQ
$23.5B
$24.3M 3.42%
2,546,443
-1,145,040
-31% -$12.6M
GOOG icon
11
Alphabet (Google) Class C
GOOG
$3.9T
$20.5M 2.9%
941,596
-2,563,493
-73% -$56.7M
URS
12
DELISTED
URS CORP
URS
$20.3M 2.86%
377,324
+17,324
+5% +$859K
DDS icon
13
Dillards
DDS
$8.87B
$19.2M 2.71%
+245,000
New +$19.8M
IONS icon
14
Ionis Pharmaceuticals
IONS
$9.35B
$18.4M 2.59%
490,000
-30,000
-6% -$896K
SPY icon
15
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$18.1M 2.55%
+107,708
New +$18.1M
ITMN
16
DELISTED
INTERMUNE INC
ITMN
$15.8M 2.22%
1,025,000
-350,000
-25% -$4.91M
UHS icon
17
Universal Health Services
UHS
$9.43B
$15.7M 2.22%
210,000
+110,000
+110% +$7.67M
NKTR icon
18
Nektar Therapeutics
NKTR
$2.39B
$15.1M 2.14%
96,667
– –
AAPL icon
19
Apple
AAPL
$4.89T
$14.3M 2.02%
840,000
-308,000
-27% -$5.11M
WCRX
20
DELISTED
WARNER CHILCOTT PLC ORD SHS CL A (IRL)
WCRX
$13M 1.83%
566,000
– –
OREX
21
DELISTED
Orexigen Therapeutics, Inc.
OREX
$12.9M 1.82%
210,000
+20,000
+11% +$1.35M
LBTYK icon
22
Liberty Global Class C
LBTYK
$3.27B
$12.8M 1.8%
418,428
– –
NBIX icon
23
Neurocrine Biosciences
NBIX
$17.7B
$11.9M 1.68%
1,050,000
+780,000
+289% +$10.7M
SHPG
24
DELISTED
Shire pic
SHPG
$8.39M 1.18%
70,000
– –
PACD
25
DELISTED
Pacific Drilling S A
PACD
$4.04M 0.57%
36,510
+9,010
+33% +$898K
1
2

Similar funds

BHCM
Boulder Hill Capital Management New York $47.9M AUM
VMV
Venrock Management VI Palo Alto, California $47.6M AUM 45.26% 1-Year Est. Return
BHH
Baker Hughes Holdings Houston, Texas $47.6M AUM 26.35% 1-Year Est. Return
LAMC
Lubert-Adler Management Company Philadelphia, Pennsylvania $49.3M AUM 17.46% 1-Year Est. Return
MAM
Miria Asset Management St. Julians, Malta $49.9M AUM 21.84% 1-Year Est. Return
BCM
BlueMar Capital Management Miami, Florida $49.9M AUM 28.76% 1-Year Est. Return
LOF
Lightspeed Opportunity Fund Menlo Park, California $50.1M AUM 53.1% 1-Year Est. Return
CLCM
Center Lake Capital Management West Palm Beach, Florida $45.8M AUM 58.23% 1-Year Est. Return

Meditor Group's Q3 2013 Portfolio in Review

As of Q3 2013, Meditor Group held 47 positions worth $709M, down 4% from $738M the previous quarter. Its ten largest holdings account for 65% of the portfolio.

Meditor Group withdrew a net $65.5M in Q3 2013, closing 11 positions and reducing 10 holdings. Its most notable exit was BlackBerry, an estimated $23.1M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 47% of assets, up from 43% a quarter earlier, followed by Consumer Discretionary and Technology.

Against the trend, Meditor Group opened a new position in J.C. Penney Company, Inc. worth $39.6M.

  • Meditor Group's largest Q3 2013 buy was J.C. Penney Company, Inc.: 4,500,000 shares worth $39.6M.
  • Meditor Group added most to Barnes & Noble in Q3 2013, an estimated $31.4M increase.
  • Meditor Group's biggest Q3 2013 reduction was ONYX PHARMACEUTICALS INC, cutting an estimated $66.7M.
  • Meditor Group fully exited BlackBerry in Q3 2013, selling an estimated $23.1M.
  • Meditor Group's ten largest holdings make up 65% of its $709M portfolio in Q3 2013.
  • Meditor Group opened 7 new positions and closed 11 in Q3 2013.
  • Meditor Group's portfolio value fell 4% quarter-over-quarter to $709M.

Based on Meditor Group's 13F filing for Q3 2013, filed 25 Oct 2013.